OBJECTIVES: The purpose of this single-institution study was to describe our 7-year intention-to-treat results, obtained with the use of endovascular techniques for the treatment of ruptured abdominal aortic aneurysms (rAAA). PATIENTS AND METHODS: From October 1998 until March 2005, a total of 28 patients were admitted or transferred to our department with an rAAA. They were all treated according to a management protocol of intention-to-treat with endovascular techniques. Twenty of the patients received endovascular treatment and the remaining 8 underwent an open surgery procedure. RESULTS: The mortality rate of the endovascularly treated patients was 40% (8 in 20), whereas of the 8 surgical patients 3 survived (mortality = 62.5%). The overall mortality rate of the 28 patients admitted with an rAAA was 46.4% (13 of 28 patients). CONCLUSIONS: In our experience the intension-to-treat protocol for rAAA offered acceptable results in terms of mortality rates. Multi-center studies are necessary to establish the role of endovascular treatment in patients with rAAA.
OBJECTIVES: The purpose of this single-institution study was to describe our 7-year intention-to-treat results, obtained with the use of endovascular techniques for the treatment of ruptured abdominal aortic aneurysms (rAAA). PATIENTS AND METHODS: From October 1998 until March 2005, a total of 28 patients were admitted or transferred to our department with an rAAA. They were all treated according to a management protocol of intention-to-treat with endovascular techniques. Twenty of the patients received endovascular treatment and the remaining 8 underwent an open surgery procedure. RESULTS: The mortality rate of the endovascularly treated patients was 40% (8 in 20), whereas of the 8 surgical patients 3 survived (mortality = 62.5%). The overall mortality rate of the 28 patients admitted with an rAAA was 46.4% (13 of 28 patients). CONCLUSIONS: In our experience the intension-to-treat protocol for rAAA offered acceptable results in terms of mortality rates. Multi-center studies are necessary to establish the role of endovascular treatment in patients with rAAA.
Authors: P Gloviczki; P C Pairolero; P Mucha; M B Farnell; J W Hallett; D M Ilstrup; B J Toomey; A L Weaver; T C Bower; R G Bourchier Journal: J Vasc Surg Date: 1992-05 Impact factor: 4.268
Authors: J A Heller; A Weinberg; R Arons; K V Krishnasastry; R T Lyon; J S Deitch; A H Schulick; H L Bush; K C Kent Journal: J Vasc Surg Date: 2000-12 Impact factor: 4.268
Authors: Neval Yilmaz; Noud Peppelenbosch; Philippe W M Cuypers; Alexander V Tielbeek; Luciën E M Duijm; Jacob Buth Journal: J Endovasc Ther Date: 2002-08 Impact factor: 3.487
Authors: Marc R H M van Sambeek; Lukas C van Dijk; Johanna M Hendriks; Martine van Grotel; Jan-Willem Kuiper; Peter M T Pattynama; Hero van Urk Journal: J Endovasc Ther Date: 2002-08 Impact factor: 3.487
Authors: April E Nedeau; Frank B Pomposelli; Allen D Hamdan; Mark C Wyers; Richard Hsu; Teviah Sachs; Jeffrey J Siracuse; Mark L Schermerhorn Journal: J Vasc Surg Date: 2012-05-23 Impact factor: 4.268
Authors: Kristina A Giles; Allen D Hamdan; Frank B Pomposelli; Mark C Wyers; Suzanne E Dahlberg; Marc L Schermerhorn Journal: J Endovasc Ther Date: 2009-10 Impact factor: 3.487
Authors: B L S Borger van der Burg; Thijs T C F van Dongen; J J Morrison; P P A Hedeman Joosten; J J DuBose; T M Hörer; R Hoencamp Journal: Eur J Trauma Emerg Surg Date: 2018-05-21 Impact factor: 3.693